Toward a treatment for thyroid hormone transporter MCT8 deficiency – achievements and challenges
European Thyroid Journal · 2024
DOI: 10.1530/etj-24-0286 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Thyroid Journal, 2024. Verfasst von Boyka Markova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetes & Metabolism, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Hauptthemen laut MEDLINE: Monocarboxylic Acid Transporters, Symporters, Muscle Hypotonia, Thyroid Hormones. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Patients with an inactive thyroid hormone (TH) transporter MCT8 (Allan–Herndon–Dudley Syndrome, AHDS) display severe neurological impairments and motor disabilities, indicating an indispensable function of MCT8 in facilitating TH access to the human brain. Consequently, the CNS of AHDS patients appears to be in a TH deficient state, which greatly compromises proper neural development and function. Another hallmark of this disease is that patients exhibit elevated serum T3 levels, leading to a hyperthyroid situation in peripheral tissues. Several treatment strategies have been developed and evaluated in preclinical mouse models as well as in patients. Here, we discuss these different therapeutic approaches to overcome MCT8 deficiency and summarize the current achievements and challenges in improving brain maturation in the absence of MCT8.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Diabetes & Metabolism, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
- Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Medical Faculty, University of Duisburg-Essen, Essen, Germany.
ORCID-Profile: Steffen Mayerl, Heike Heuer
Zitieren
APA
Markova, B., Mayerl, S., & Heuer, H. (2024). Toward a treatment for thyroid hormone transporter MCT8 deficiency – achievements and challenges. European Thyroid Journal. https://doi.org/10.1530/etj-24-0286
Vancouver
Markova B, Mayerl S, Heuer H. Toward a treatment for thyroid hormone transporter MCT8 deficiency – achievements and challenges. European Thyroid Journal. 2024. doi:10.1530/etj-24-0286
BibTeX
@article{Markova2024,
author = {Markova, Boyka and Mayerl, Steffen and Heuer, Heike},
title = {Toward a treatment for thyroid hormone transporter MCT8 deficiency – achievements and challenges},
journal = {European Thyroid Journal},
year = {2024},
doi = {10.1530/etj-24-0286}
}
EUVIMED